BOW

Business Context and Reporting Period

Company: Bowhead Specialty Holdings Inc. (NYSE: BOW)
Filing Type: Form 10-Q (Unaudited)
Period Ended: June 30, 2024
Business Overview: Bowhead is a specialty property and casualty insurance holding company focusing on Casualty, Professional Liability, and Healthcare risks. It operates primarily on an excess and surplus (E&S) basis through a strategic partnership with American Family Mutual Insurance Company (AmFam). The company completed an Initial Public Offering (IPO) in May 2024, raising approximately $131.0 million in net proceeds.

Key Financial Metrics (Six Months Ended June 30, 2024)

Material Changes vs. Prior Period

• Premium Growth: Gross written premiums increased 47.8% to $314.0 million, driven by new business and renewals across all divisions. Net written premiums rose 44.5% to $202.9 million.
• Profitability: Net income increased 8.6% to $12.5 million compared to $11.6 million in the prior year. However, GAAP net income was impacted by non-operating expenses related to the IPO and the acceleration of stock-based compensation.
• Underwriting Performance: The combined ratio increased to 98.7% from 93.5% in the prior year. The loss ratio rose 4.9 points to 65.5%, primarily due to a higher proportion of Casualty business (which has higher industry loss ratios) and updated loss ratio assumptions. The expense ratio increased slightly to 33.2%.
• Investment Income: Net investment income surged 122.1% to $16.4 million, attributed to a larger average investment balance and higher yields.
• Balance Sheet: Total assets grew 35.8% to $1.4 billion, and stockholders' equity increased 76.9% to $339.9 million, largely due to IPO proceeds and capital contributions.

Guidance, Outlook, and Risks

• Outlook: Management expects to continue growing the business profitably, leveraging its strategic relationship with AmFam. The company plans to use IPO proceeds to support premium growth and general corporate purposes.
• Unusual Items:
  • IPO Costs: Non-operating expenses of $1.7 million were incurred related to the IPO.
  • Stock-Based Compensation: $1.3 million of remaining unrecognized compensation costs for Class P Interests were accelerated into operating expenses in Q2 2024.
  • Strategic Initiatives: Costs of $2.7 million were incurred to set up the new Baleen Specialty division.
• Key Risks:
  • AmFam Dependency: The company relies heavily on its strategic partnership with AmFam for licenses, ratings, and distribution. Termination of this relationship would materially adversely affect operations.
  • Reserve Adequacy: As with all insurers, there is a risk that loss reserves may be inadequate to cover actual losses, particularly given the company's limited operating history.
  • Reinsurance Credit Risk: While 100% of reinsurers are rated "A" or better, there is a risk of reinsurer non-payment or insolvency.
  • Market Cyclicality: The insurance industry is cyclical; a shift to a "soft market" could reduce pricing power and profitability.

Investor Verification Checklist

• AmFam Relationship Stability: Verify the terms and duration of the Managing General Agency (MGA) and Quota Share agreements with AmFam.
• Loss Reserve Development: Monitor future quarters for any adverse development in loss reserves, particularly in the Casualty line which drives the majority of premium growth.
• Expense Ratio Sustainability: Assess whether the expense ratio can normalize as one-time IPO and strategic initiative costs are excluded in future periods.
• Reinsurance Concentration: Review the top five reinsurers (Renaissance, Endurance, Markel, Ascot, Partner) and their financial strength ratings.
• Liquidity and Capital: Confirm the company's ability to meet statutory capital requirements in Wisconsin and its $75 million revolving credit facility covenants.